Scarica l'app Stockscreener
0.5024
10.38%
-0.0582
Dopo l'orario di chiusura:
.50
-0.0024
-0.48%
Precedente Chiudi:
$0.5606
Aprire:
$0.5622
Volume 24 ore:
1.50M
Relative Volume:
1.19
Capitalizzazione di mercato:
$3.15M
Reddito:
$23.45M
Utile/perdita netta:
$-19.98M
Rapporto P/E:
-0.0398
EPS:
-12.63
Flusso di cassa netto:
$-2.65M
1 W Prestazione:
-10.76%
1M Prestazione:
+14.44%
6M Prestazione:
-22.11%
1 anno Prestazione:
-32.47%
Intervallo 1D:
$0.43
$0.5622
Intervallo di 1 settimana:
$0.43
$0.8173
Portata 52W:
$0.3111
$1.34
cbdMD Inc Stock (YCBD) Company Profile
Nome
cbdMD Inc
Settore
Telefono
704-445-5800
Indirizzo
4521 Sharon Road, Charlotte, NC
Confronta YCBD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
YCBD
cbdMD Inc
|
0.5024 | 3.15M | 23.45M | -19.98M | -2.65M | -12.63 |
|
ZTS
Zoetis Inc
|
165.89 | 74.84B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
12.92 | 40.96B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.92 | 24.83B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
143.26 | 14.50B | 2.24B | 385.90M | 440.10M | 3.73 |
cbdMD Inc Borsa (YCBD) Ultime notizie
cbdMD Announces It Has Fully Satisfied Its Notes - The Kingston Whig-Standard
cbdMD Eliminates All Debt Through Early Note Conversion, Strengthens Financial Position - StockTitan
cbdMD announces additional conversions of its convertible notes - MSN
cbdMD Announces Additional Conversions of Its Convertible Notes - The Kingston Whig-Standard
cbdMD discloses NYSE listing compliance notice - MSN
cbdMD receives NYSE non-compliance notice - MSN
cbdMD Faces NYSE American Delisting Risk Over $2M Equity Requirement Shortfall - StockTitan
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard - Yahoo Finance
cbdMD (AMEX:YCBD) Stock Quotes, Forecast and News Summary - Benzinga
cbdMD Expands Board with CEO T. Ronan Kennedy - MSN
cbdMD Strengthens Leadership: CEO Kennedy Joins Board After Successful Business Turnaround - StockTitan
cbdMD posts lower annual sales, mixed fourth quarter - Green Market Report
cbdMD Inc. (YCBD) reports earnings - Quartz
cbdMD Slashes Losses by $19.1M Despite Sales Dip; Launches New Product Lines - StockTitan
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results - The Kingston Whig-Standard
Dream Industrial REIT (DIR-UN-T) QuotePress Release - The Globe and Mail
cbdMD, Inc. Reschedules Earnings Release and Conference Call - Newsfile
S&P 500 Information Technology [Sector] (SRIT) QuotePress Release - The Globe and Mail
cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results - The Kingston Whig-Standard
YCBD Stock Touches 52-Week Low at $0.41 Amid Market Challenges - Investing.com
cbdMD Extends Lease on Executive Office and Warehouse By Investing.com - Investing.com Canada
cbdMD Extends Lease on Executive Office and Warehouse - Investing.com
CbdMD : Learn whether hemp cultivation and CBD production is truly sustainable by examining factors like water usage, soil health, and carbon footprint. - Marketscreener.com
CbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers - Barchart
cbdMD Launches THC Seltzers in $4B Market Push with Fast-Acting Technology | YCBD Stock News - StockTitan
cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers - Newsfile
CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine - Quantisnow
YCBD stock touches 52-week low at $0.43 amid market challenges - Investing.com
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG Pain Relief Cream, Setting the Stage for Unprecedented Growth - Quantisnow
cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 2.5% – What’s Next? - Defense World
CBD Life Sciences, Inc. (CBDL) Announces Strategic MOU With U.S. Armed Forces for Groundbreaking Mushroom Supplement - Quantisnow
YCBD stock touches 52-week low at $0.44 amid market challenges By Investing.com - Investing.com South Africa
YCBD stock touches 52-week low at $0.44 amid market challenges - Investing.com
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products - Quantisnow
CBD Life Sciences, Inc. (CBDL) Launches First-of-Its-Kind CBD Horse Paste: A Veterinarian-Designed Solution for Equine Wellness - Quantisnow
CBD Life Sciences Inc. (CBDL) Ignites Expanding Revenue Stream With RangeMe, Poised for Explosive Growth - Quantisnow
Top Podcasts Partner with cbdMD - cbdMD
cbdMD Launches Line of CBD Products with Wegmans Food Markets - Newsfile
cbdMD Joins Forces with Life Time - cbdMD
CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness - Quantisnow
Wegmans to start carrying cbdMD CBD products - Supermarket News
cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 6.1% - Defense World
cbdMD secures trademark, amends agreements - Investing.com India
cbdMD secures trademark, amends agreements By Investing.com - Investing.com Australia
The Future of Hemp: Innovations in Sustainability - cbdMD
CBD Life Sciences, Inc. Expands Footprint With Proposed Strategic Acquisition of Interest in Two New York Cannabis Dispensaries - Quantisnow
cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American - Yahoo Finance
cbdMD resolves lease obligations, anticipates gain - Investing.com India
cbdMD Reduces Operating Loss, Reports Positive Net Income For Q3 And 15% YoY Drop In Net Sales - Benzinga
cbdMD, Inc. (AMEX:YCBD) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: cbdMD reports Q3 results with focus on strategic growth - Investing.com Canada
cbdMD Inc Azioni (YCBD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.94%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):